anti-IFN gamma (Advanced Biotherapy)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-IFN gamma (Advanced Biotherapy)
Drug Alias NameAGT-1anti-cytokine therapy (Advanced Biotherapy)anti-cytokine antibodies (Advanced Biotherapy)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterferon gamma receptor antagonistsTumor necrosis factor inhibitors
TargetsInterferon gamma receptorTumor necrosis factor
Therapy Area/IndicationsRejection of organ transplantationDiabetes Mellitus, Type 1Pemphigus +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRussian Federation
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdvanced Biotherapy Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Biotherapy Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationDiabetes Mellitus, Type 1Pemphigus +[13] 

Other Information

ATC CodeN/A
Related LinksN/A